Iridex (NASDAQ:
IRIX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $11.799 million which missed the analyst consensus estimate of $11.910 million by 0.93 percent. This is a 0.82 percent decrease over sales of $11.896 million the same period last year.